i am going to buy some more here - i think CCX872 will show positive effect in pancreatic cancer based on ASCO data for competitor CCR2 inhibitor provided in April 2016.
May not see pancreatic cancer data for a while cause study is ongoing and just recently stopped recruiting patients. Market may sense no new data in near term.
i think some viewed the data as lacking in terms of efficacy (BVAS) clarity - although they've already released on efficacy in separate study. Next up - pancreatic cancer. That study says "active" and no longer enrolling (it was enrolling still about a month ago). When this PC study reads out - and if it's consistent with what has been reported at ASCO for a competitor CCR2 inhibitor - then the stock should move up decently and certainly firm more as well.
TD does periodic psychological assessments - in this case, they decided u should not own this or frankly any stock
i agree-presentation was bland, at best. The CEO starts by talking about 2016 as transformative but then just provides basics of CCX168 and very little mention of near term data catalysts.
if you believe that a down trend in CCXI down to below $4 is a significant risk and possibility, sell it. I am holding since i think there is a better than 60% chance that new data will be released over next 1-3 months that will be supportive of higher prices.
try it - it changes your perspective on life and can actually make you happier (or at least less annoyed)
and where is tradingexpert4me? Only comes out on down days and always says that he saw it coming and timed it exactly right. Possibly the most annoying poster around - which is why is on "ignore"
The Jefferies conference is next Wed - i think those updates are helpful particularly where new data is expected in near term which is the case here
yes - i know you can "ignore" a user but then it seems that i lose a thread or threads as well which is annoying
i agree - i plan to hold for a long time (at least a year) unless the data/news flow change significantly changes my investment thesis on this one
tradingexpert4me is a) one of many manic posters on these stock message boards, b) a whacko who changes his/her views depending on whatever, c) likely from somewhere outside the US based on his writing (my guess is somewhere in Asia). If i could block his posts here so i wouldn't have to see them, i would - he adds essentially value to the board
he's a whacko day trader. these boards are full of them. i think we are just seeing some profit taking. Short activity? V. hard to say - more likely profit taking in my view since CCXI has ramped nicely in the past month
if you go to clinicaltrials.gov, you'll see that CCXI has several trials that are ongoing or now completed, so the data flow should happen starting in June and i hope extending throughout the remainder of summer and rest of year
it's in phase I for pancreatic cancer, not ph II - but i think you'll see responses although whether that will translate to longer PFS and OS is hard to say.